TG Therapeutics | Betriebsaufwand



Operating Expenses Veränderung Datum
AbbVie USD 9.61B 6.98B 2025-03
Alaunos Therapeutics USD 759K 391K 2024-12
Amgen USD 6.86B 85M 2025-03
Ardelyx USD 108M 12M 2024-12
Arrowhead Research USD 161.51M 2.4M 2025-03
Bayer EUR 11.41B 3.22B 2025-03
Biogen USD 2.12B 106.5M 2025-03
Corcept Therapeutics USD 153.8M 2.83M 2025-03
Dynavax Technologies USD 91.79M 18.13M 2025-03
Gilead Sciences USD 4.43B 687M 2025-03
J&J USD 8.26B 10.37B 2025-03
Novartis USD 11.28B 1.73B 2024-12
PTC Therapeutics USD 205.87M 69.79M 2025-03
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
TG Therapeutics USD 78.24M 6.79M 2024-12
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12



TG Therapeutics Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.